Atomoxetine, Serum or Plasma

Alphabetical Test listing

Atomoxetine, Serum or Plasma-994

  
Atomoxetine, Serum or Plasma
  
994
  
LAB994
  
MSO
  
Strattera
  

Therapeutic drug management

  

Trough levels are most reproducible.

  
Serum
  
  
2 mL
  
0.5 mL
  

Immediately following collection, thoroughly mix sample by gently inverting 5 times

  
  1. Allow sample to clot
  2. Spin within two (2) hours of sample collection
  3. Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum
  
Dk green heparin (Li or Na), no gel
  

  

  

Immediately after collection, mix tube thoroughly by gentle inversion, 8 - 10 times, to prevent clotting

  
  1. Spin within two (2) hours of sample collection
  2. Transfer plasma to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as the appropriate plasma type
  

Refrigerated (preferred) – 7 days

Ambient – 3 days

Frozen – 6 months

  

Gel-barrier tubes

  
LabCorp (790640): R-LC
  
1 x week
  
7 - 10 days
  

Liquid chromatography/tandem mass spectrometry (LC/MS-MS)

  

Therapeutic range has not been established. Poor metabolizers of cytochrome P450 2D6 (CYP2D6) substrates may have steady-state atomoxetine concentrations sixfold greater than those of extensive metabolizers.

  
80299
  
03/23/2023
  
03/23/2023